DCF — CAMBRIDGE MEDICAL CENTER
Enterprise Value: $-28.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-28.7M
Enterprise Value
$-11.4M
PV of Cash Flows
$-17.3M
PV of Terminal Value
$-27.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $87.4M | $-0.5M | -1.0% | $-4.2M | $-3.8M |
| Year 2 | $90.0M | $0.4M | 0.0% | $-3.4M | $-2.8M |
| Year 3 | $92.7M | $1.3M | 1.0% | $-2.6M | $-2.0M |
| Year 4 | $95.5M | $1.8M | 2.0% | $-2.2M | $-1.5M |
| Year 5 | $98.4M | $2.1M | 2.0% | $-2.0M | $-1.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-28.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$84.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.010905833164285506
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5